Cardio Diagnostics Holdings, Inc. (CDIO)

Stammdaten

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Unternehmen & Branche

NameCardio Diagnostics Holdings, Inc.
TickerCDIO
CIK0001870144
BoerseUS
SektorHealthcare
IndustrieBiotechnology

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung3,1 Mio. USD
Beta2,66
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K14,825-6,498,167-3.717,766,4156,973,354
2025-09-3010-Q2,855-1,714,536-0.988,788,9028,151,571
2025-06-3010-Q7,475-1,683,199-0.9710,396,5479,724,699
2025-03-3110-Q940-1,635,064-0.9712,282,11811,377,120
2024-12-3110-K34,890-8,383,453-9.3510,615,3129,557,788
2024-09-3010-Q6,580-1,412,566-1.734,481,4613,686,185
2024-06-3010-Q7,870-1,287,995-1.713,996,7653,074,236
2024-03-3110-Q15,928-4,163,584-5.934,327,5633,036,801
2023-12-3110-K17,065-8,376,834-0.664,462,3652,958,124
2023-09-3010-Q10,030-1,932,382-0.165,963,3072,287,731
2023-06-3010-Q1,725-4,022,905-0.396,756,9042,908,524
2023-03-3110-Q0-1,032,618-0.118,551,6113,422,115
2022-12-3110-K950-4,660,985-1.516,249,4784,301,708
2022-09-3010-Q0-1,150,875-0.1765,801,4359,572,614
2022-06-3010-Q0-841,998-0.1665,196,8529,702,783
2022-03-3110-Q0-290,055-0.0765,640,611778,054
2021-12-3110-K901-144,837-0.531,101,9941,068,109
2021-09-3010-Q-72124,279
2021-06-3010-Q-39724,603

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×